In the BioHarmony Drug Report Database

"Preview" Icon

Cyproheptadine

Periactin (cyproheptadine) is a small molecule pharmaceutical. Cyproheptadine was first approved as Periactin on 1982-01-01. It is used to treat allergic rhinitis perennial, blepharospasm, cluster headache, dyskinesias, and nelson syndrome amongst others in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target alpha-1B adrenergic receptor, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 7, alpha-1D adrenergic receptor, alpha-1A adrenergic receptor, and histone-lysine N-methyltransferase SETD7.

 

Trade Name

 

Periactin
 

Common Name

 

cyproheptadine
 

ChEMBL ID

 

CHEMBL516
 

Indication

 

allergic rhinitis perennial, blepharospasm, cluster headache, dyskinesias, nelson syndrome, pruritus, schizophrenia, spastic paraparesis, urticaria
 

Drug Class

 

Image (chem structure or protein)

Cyproheptadine structure rendering